Annexin A2 plays a critical role in epithelial ovarian cancer

Archives of Gynecology and Obstetrics

Volumn 292, Issue 1, 2015, Pages 175-182

  Deng, Yan ^a   Chen, Chen ^a   Hua, Minhui ^a   Xi, Qinghua ^a   Liu, Rong ^a   Yang, Shuyun ^a   Liu, Jian ^a   Zhong, Jianxin ^a   Tang, Meilan ^a   Lu, Shumin ^a   Tang, Chunhui ^a   Wang, Yingying ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Annexin A2; Human epithelial ovarian cancer; Prognosis; Proliferation

Indexed keywords

LIPOCORTIN 2;

ADULT; AGED; CELL PROLIFERATION; DISEASE COURSE; FEMALE; HUMAN; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; ANNEXIN A2; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 84939980260     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3598-5     Document Type: Article

References (26)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300. doi:10.3322/caac.20073
2. Su D, Xu H, Feng J, Gao Y, Gu L, Ying L, Katsaros D, Yu H, Xu S, Qi M (2012) PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer. J Transl Med 10:31. doi:10.1186/1479-5876-10-31
3. Ozols RF (2002) Update on the management of ovarian cancer. Cancer J 8(Suppl 1):S22–S30
4. Chen J, Wang M, Xi B, Xue J, He D, Zhang J, Zhao Y (2012) SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer. PLoS One 7(8):e42413. doi:10.1371/journal.pone.0042413
5. Lokman NA, Ween MP, Oehler MK, Ricciardelli C (2011) The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron 4(2):199–208. doi:10.1007/s12307-011-0064-9
6. Liu J, Vishwanatha JK (2007) Regulation of nucleo-cytoplasmic shuttling of human annexin A2: a proposed mechanism. Mol Cell Biochem 303(1–2):211–220. doi:10.1007/s11010-007-9477-7
7. Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, Shroyer KR, Hajjar KA, Tsirka SE (2011) Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci 31(40):14346–14360. doi:10.1523/JNEUROSCI.3299-11.2011
8. Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC (2006) Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 81(2):146–156. doi:10.1016/j.yexmp.2006.03.003
9. Diaz VM, Hurtado M, Thomson TM, Reventos J, Paciucci R (2004) Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 53(7):993–1000
10. Shiozawa Y, Havens AM, Jung Y, Ziegler AM, Pedersen EA, Wang J, Lu G, Roodman GD, Loberg RD, Pienta KJ, Taichman RS (2008) Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem 105(2):370–380. doi:10.1002/jcb.21835
11. Tressler RJ, Updyke TV, Yeatman T, Nicolson GL (1993) Extracellular annexin II is associated with divalent cation-dependent tumor cell-endothelial cell adhesion of metastatic RAW117 large-cell lymphoma cells. J Cell Biochem 53(3):265–276. doi:10.1002/jcb.240530311
12. Ito Y, Arai K, Nozawa R, Yoshida H, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Kuma K, Miyauchi A (2007) S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma. Anticancer Res 27(4C):2679–2683
13. Wang CY, Chen CL, Tseng YL, Fang YT, Lin YS, Su WC, Chen CC, Chang KC, Wang YC, Lin CF (2012) Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. J Biol Chem 287(39):32512–32524. doi:10.1074/jbc.M112.351957
14. Lokman NA, Elder AS, Ween MP, Pyragius CE, Hoffmann P, Oehler MK, Ricciardelli C (2013) Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget 4(8):1199–1211
15. Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Bukawa H (2012) Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest. BMC Cancer 12:321. doi:10.1186/1471-2407-12-321
16. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30. doi:10.3322/caac.21166
17. Zhang Q, Ye Z, Yang Q, He X, Wang H, Zhao Z (2012) Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. World J Surg Oncol 10:103. doi:10.1186/1477-7819-10-103
18. Frances R, Tumang JR, Rothstein TL (2007) Extreme skewing of annexin II and S100A6 expression identified by proteomic analysis of peritoneal B-1 cells. Int Immunol 19(1):59–65. doi:10.1093/intimm/dxl122
19. Waisman DM (1995) Annexin II tetramer: structure and function. Mol Cell Biochem 149–150:301–322
20. Puisieux A, Ji J, Ozturk M (1996) Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanisms. Biochem J 313(Pt 1):51–55
21. Matsumoto T, Murao S, Kito K, Kihana T, Matsuura S, Ueda N (1997) Modulation of S-100 genes response to growth conditions in human epithelial tumor cells. Pathol Int 47(6):339–346
22. Huang Y, Jin Y, Yan CH, Yu Y, Bai J, Chen F, Zhao YZ, Fu SB (2008) Involvement of Annexin A2 in p53 induced apoptosis in lung cancer. Mol Cell Biochem 309(1–2):117–123. doi:10.1007/s11010-007-9649-5
23. Vishwanatha JK, Chiang Y, Kumble KD, Hollingsworth MA, Pour PM (1993) Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 14(12):2575–2579
24. Bao H, Jiang M, Zhu M, Sheng F, Ruan J, Ruan C (2009) Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int J Hematol 90(2):177–185. doi:10.1007/s12185-009-0356-8
25. Braden AR, Kafka MT, Cunningham L, Jones H, Vishwanatha JK (2009) Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth. J Nanosci Nanotechnol 9(5):2856–2865
26. Madureira PA, Hill R, Miller VA, Giacomantonio C, Lee PW, Waisman DM (2011) Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. Oncotarget 2(12):1075–1093